Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sleep apnea mask put to the test

NCT ID NCT06060717

Symptom relief Sponsor: Fisher and Paykel Healthcare Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study tested a new nasal mask called the F&P Caramel for people with obstructive sleep apnea. 45 adults who already use a similar mask tried it at home for 14 days. Researchers measured how well the mask controlled breathing pauses (AHI score) and daytime sleepiness. The goal was to see if the mask is safe and works well in everyday use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
F&P Caramel nasal mask (device)
What this could lead to
If successful, this mask could offer a comfortable, effective option for managing sleep apnea with positive airway pressure therapy.
What could go wrong
This is a small, completed device evaluation with no control group. Results may not apply to all users, and individual comfort or fit can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Nov 2023

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Persons who are ≥22 years of age * Persons who weigh ≥66 pounds * Persons who have been prescribed PAP therapy by a physician * Persons who are existing nasal mask or sub-nasal mask users with ≥3 months of use prior to enrolment in the clinical trial * Persons who are compliant with PAP therapy for ≥4 hours per night for ≥70% of nights for a 14-day period within 30 days prior to enrolment in the clinical trial * Persons who are fluent in spoken and written English * Persons who possess the capacity to provide informed consent Exclusion Criteria: * Persons who are intolerant to PAP therapy * Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate * Persons who are required to use PAP therapy for \>12 hours per day or for extensive periods, not including sleep or naps * Persons who are trying to get pregnant, are pregnant, or think they may be pregnant * Persons who have an IPAP pressure of \>30 cmH2O if on BPAP * Persons who use a PAP therapy device for the delivery of medicines, except supplemental oxygen * Persons who use a PAP therapy device that does not possess data recording capabilities to capture AHI and a numerical indicator of leak that is accessible to the investigation site

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea

Contacts and locations

Locations

  • Clayton Sleep Institute

    St Louis, Missouri, 63123, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.